Paralysis News and Research

RSS

Paralysis is the loss of muscle function in part of your body. It happens when something goes wrong with the way messages pass between your brain and muscles. Paralysis can be complete or partial. It can occur on one or both sides of your body. It can also occur in just one area, or it can be widespread. Paralysis of the lower half of your body, including both legs, is called paraplegia. Paralysis of the arms and legs is quadriplegia.

Taipan venom may stop excessive bleeding during vascular surgery

A blood-clotting protein in taipan venom has been identified by Queensland University of Technology PhD researcher Liam St Pierre to rapidly stop excessive bleeding during vascular surgery and major trauma.

9 Mar 2006

Will the FDA rise to the occasion and admit their natalizumab mistake?

When Anita Louise Smith enrolled in an experimental drug trial in 2002 in Colorado, she had a diagnosis of multiple sclerosis but no symptoms and was looking to reduce the chances of being ravaged by the disease.

7 Mar 2006

Extensive study of natalizumab

Scientists have completed an extensive study of more than 3,000 patients who received a promising anti-inflammatory drug, natalizumab, that was linked to three cases of a serious brain infection in large clinical trials halted in early 2005.

7 Mar 2006

Spinocerebellar ataxia and other neurodegenerative diseases might be treatable with drugs that alter the activity of potassium channels

For the first time, researchers have linked mutations in a gene that regulates how potassium enters cells to a neurodegenerative disease and to another disorder that causes mental retardation and coordination problems.

27 Feb 2006

SRY protein explains why men more likely to develop Parkinson's

Scientists at Prince Henry's Institute, Melbourne, and the University of California, Los Angeles, have discovered that SRY, the male protein that forms the testes is also produced in the brain region affected in Parkinson's disease.

24 Feb 2006

First potential treatment for intracerebral hemorrhage

The first potential treatment for strokes that result from bleeding in the brain is under study at the Medical College of Georgia.

18 Jan 2006

Nasal flu vaccine just as safe as a jab

According to U.S. government researchers, a new nasal vaccine against influenza, which helps patients avoid the needle, has caused no unexpected side-effects.

7 Dec 2005

Epidural versus non-epidural or no analgesia in labour

Women who receive epidurals during labor report less pain than those who choose opiates or natural childbirth, according to a systematic review of evidence.

28 Nov 2005

Gene therapy and exercise may help sufferers of Lou Gehrig's disease

A new study in mice gives hope that a combination of gene therapy and exercise may extend the lives of people who have Lou Gehrig's disease.

15 Nov 2005

Novel technique to remove tumors from the cervical region of the spine

University of California - San Francisco (UCSF) surgeons are using a novel technique to remove tumors from the cervical region of the spine that were previously thought "inoperable."

7 Nov 2005

Alien abduction may be all in the mind

New research presented at the Science Museum's Dana Centre, supports what scientists have long argued: that people who report contact with aliens have a psychological profile that might make them more susceptible to false memories.

27 Oct 2005

Gamma Knife Stereotactic Radiosurgery (GKRS) is an effective treatment for trigeminal neuralgia

"This has proven to be a safe, effective treatment for trigeminal neuralgia patients, without the potential facial paralysis and long-term recovery experienced with conventional surgery," said Volker Stieber, M.D., co-director of the Gamma Knife Program at Wake Forest Baptist.

19 Oct 2005

Third nationwide polio drive in Indonesia in attempt to eliminate the disease

Indonesia which is still battling to eliminate the recurring outbreak of polio, will hold a third nationwide polio immunisation drive in November to try to finally stamp out the crippling disease.

19 Oct 2005

Effective removal of face masks from players who sustain c-spine injuries

This fall, as more than a million high school football players take to the gridiron, University of New Hampshire's Erik Swartz is focused on the worst-case scenario.

28 Sep 2005

Still a long way to go in diagnostic evaluation of all patients who suffer ischemic strokes

Women who survive a stroke are less likely than men to get crucial tests of their heart and neck arteries that can help improve their treatment and reduce their risk of a second stroke, a new University of Michigan study finds.

27 Sep 2005

Gene responsible for Neuralgic Amyotrophy identified

Neuralgic Amyotrophy is a painful disorder of the peripheral nervous system. This heritable disease causes prolonged acute attacks of pain in the shoulder or arm, followed by temporary paralysis.

27 Sep 2005

Discovery of molecule that causes transverse myelitis

Hopkins researchers have discovered a single molecule that is a cause of an autoimmune disease in the central nervous system, called transverse myelitis (TM), that is related to multiple sclerosis.

26 Sep 2005

Aquaporin-4 is the first specific molecule to be defined as a target for the autoimmune response in any form of MS

Researchers have identified a molecular suspect in a disorder similar to multiple sclerosis (MS) that attacks the optic nerve and spinal cord, according to a report presented at the 130th annual meeting of the American Neurological Association in San Diego. The protein, called aquaporin-4, is a channel protein that allows water to move in and out of cells.

26 Sep 2005

Adult human neural stem cells used to successfully regenerate spinal cord tissue

Researchers at the UC Irvine Reeve-Irvine Research Center have used adult human neural stem cells to successfully regenerate damaged spinal cord tissue and improve mobility in mice.

26 Sep 2005

New research adds to the emerging range of functions that miRNAs perform in an organism

In an effort to understand the biological function of the microRNA mir1, Drs. Nicholas Sokol and Victor Ambros (Darmouth Medical School) have studied the expression profile, transcriptional regulation and loss-of-function phenotype of Drosophila mir-1 (Dmir-1).

20 Sep 2005